CRSP logo

CRISPR Therapeutics AG (CRSP) Cash From Investing

Annual CFI:

-$280.48M-$655.13M(-174.87%)
December 31, 2024

Summary

  • As of today, CRSP annual cash from investing is -$280.48 million, with the most recent change of -$655.13 million (-174.87%) on December 31, 2024.
  • During the last 3 years, CRSP annual cash from investing has risen by +$754.95 million (+72.91%).
  • CRSP annual cash from investing is now -174.87% below its all-time high of $374.65 million, reached on December 31, 2023.

Performance

CRSP Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPcash flow metrics

Quarterly CFI:

$69.98M+$89.73M(+454.22%)
June 30, 2025

Summary

  • As of today, CRSP quarterly cash from investing is $69.98 million, with the most recent change of +$89.73 million (+454.22%) on June 30, 2025.
  • Over the past year, CRSP quarterly cash from investing has increased by +$196.88 million (+155.14%).
  • CRSP quarterly cash from investing is now -67.74% below its all-time high of $216.92 million, reached on June 30, 2023.

Performance

CRSP Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPcash flow metrics

TTM CFI:

-$5.55M+$196.88M(+97.26%)
June 30, 2025

Summary

  • As of today, CRSP TTM cash from investing is -$5.55 million, with the most recent change of +$196.88 million (+97.26%) on June 30, 2025.
  • Over the past year, CRSP TTM cash from investing has increased by +$179.26 million (+96.99%).
  • CRSP TTM cash from investing is now -101.48% below its all-time high of $374.65 million, reached on December 31, 2023.

Performance

CRSP TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CRSP Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-174.9%+155.1%+97.0%
3Y3 Years+72.9%+224.8%+99.3%
5Y5 Years-10000.0%+2041.1%+98.3%

CRSP Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-174.9%+72.9%-67.7%+139.9%-101.5%+98.8%
5Y5-Year-174.9%+72.9%-67.7%+112.4%-101.5%+99.5%
All-TimeAll-Time-174.9%+72.9%-67.7%+112.4%-101.5%+99.5%

CRSP Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$69.98M(+454.2%)
-$5.55M(+97.3%)
Mar 2025
-
-$19.75M(-118.7%)
-$202.44M(+27.8%)
Dec 2024
-$280.48M(-174.9%)
$105.83M(+165.5%)
-$280.48M(+40.0%)
Sep 2024
-
-$161.60M(-27.3%)
-$467.76M(-153.1%)
Jun 2024
-
-$126.91M(-29.8%)
-$184.81M(-216.2%)
Mar 2024
-
-$97.80M(-20.1%)
$159.02M(-57.6%)
Dec 2023
$374.65M(+244.8%)
-$81.45M(-167.1%)
$374.65M(+33.5%)
Sep 2023
-
$121.35M(-44.1%)
$280.57M(+13.7%)
Jun 2023
-
$216.92M(+84.1%)
$246.68M(+1037.6%)
Mar 2023
-
$117.83M(+167.1%)
-$26.31M(+89.8%)
Dec 2022
-$258.65M(+75.0%)
-$175.53M(-300.7%)
-$258.65M(-181.6%)
Sep 2022
-
$87.46M(+256.0%)
-$91.84M(+87.7%)
Jun 2022
-
-$56.07M(+51.0%)
-$744.48M(+24.2%)
Mar 2022
-
-$114.52M(-1213.8%)
-$982.05M(+5.2%)
Dec 2021
-$1.04B(-91.3%)
-$8.72M(+98.5%)
-$1.04B(+15.9%)
Sep 2021
-
-$565.18M(-92.5%)
-$1.23B(-23.6%)
Jun 2021
-
-$293.64M(-74.9%)
-$996.11M(-41.1%)
Mar 2021
-
-$167.90M(+17.8%)
-$706.08M(-30.5%)
Dec 2020
-$541.17M
-$204.24M(+38.2%)
-$541.17M(-64.1%)
Sep 2020
-
-$330.33M(-9063.1%)
-$329.87M(>-9900.0%)
Jun 2020
-
-$3.60M(-20.5%)
-$2.00M(-251.5%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$2.99M(-142.4%)
-$569.00K(-142.9%)
Dec 2019
$1.32M(+147.8%)
$7.06M(+386.8%)
$1.32M(+119.7%)
Sep 2019
-
-$2.46M(-13.2%)
-$6.73M(-35.6%)
Jun 2019
-
-$2.17M(-98.2%)
-$4.97M(-49.8%)
Mar 2019
-
-$1.10M(-9.7%)
-$3.31M(-19.5%)
Dec 2018
-$2.77M(+66.6%)
-$1.00M(-43.9%)
-$2.77M(-40.2%)
Sep 2018
-
-$695.00K(-32.9%)
-$1.98M(+58.6%)
Jun 2018
-
-$523.00K(+5.8%)
-$4.78M(+14.5%)
Mar 2018
-
-$555.00K(-170.7%)
-$5.58M(+32.8%)
Dec 2017
-$8.31M(-126.1%)
-$205.00K(+94.1%)
-$8.31M(-191.2%)
Sep 2017
-
-$3.49M(-162.7%)
$9.12M(+5.4%)
Jun 2017
-
-$1.33M(+59.5%)
$8.65M(-3.2%)
Mar 2017
-
-$3.29M(-119.1%)
$8.93M(-72.0%)
Dec 2016
$31.88M(+2862.9%)
$17.23M(+534.8%)
$31.88M(+117.5%)
Sep 2016
-
-$3.96M(-278.4%)
$14.66M(-21.3%)
Jun 2016
-
-$1.05M(-105.3%)
$18.62M(-4.8%)
Mar 2016
-
$19.67M(>+9900.0%)
$19.57M(>+9900.0%)
Dec 2015
-$1.15M(>-9900.0%)
-
-
Jun 2015
-
-$102.00K(>-9900.0%)
-$102.00K(>-9900.0%)
Mar 2015
-
$0.00
$0.00
Dec 2014
$0.00
-
-

FAQ

  • What is CRISPR Therapeutics AG annual cash from investing?
  • What is the all-time high annual cash from investing for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual cash from investing year-on-year change?
  • What is CRISPR Therapeutics AG quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly cash from investing year-on-year change?
  • What is CRISPR Therapeutics AG TTM cash from investing?
  • What is the all-time high TTM cash from investing for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG TTM cash from investing year-on-year change?

What is CRISPR Therapeutics AG annual cash from investing?

The current annual cash from investing of CRSP is -$280.48M

What is the all-time high annual cash from investing for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual cash from investing is $374.65M

What is CRISPR Therapeutics AG annual cash from investing year-on-year change?

Over the past year, CRSP annual cash from investing has changed by -$655.13M (-174.87%)

What is CRISPR Therapeutics AG quarterly cash from investing?

The current quarterly cash from investing of CRSP is $69.98M

What is the all-time high quarterly cash from investing for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly cash from investing is $216.92M

What is CRISPR Therapeutics AG quarterly cash from investing year-on-year change?

Over the past year, CRSP quarterly cash from investing has changed by +$196.88M (+155.14%)

What is CRISPR Therapeutics AG TTM cash from investing?

The current TTM cash from investing of CRSP is -$5.55M

What is the all-time high TTM cash from investing for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM cash from investing is $374.65M

What is CRISPR Therapeutics AG TTM cash from investing year-on-year change?

Over the past year, CRSP TTM cash from investing has changed by +$179.26M (+96.99%)
On this page